Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy

被引：0
|
作者：
Huizing, D. [1 ]
Aalbersberg, E. A. [1 ]
Versleijen, M. W. J. [1 ]
Tesselaar, M. E. T. [1 ]
Walraven, I. [1 ]
Lahaye, M. J. [1 ]
de Wit-van der Veen, B. J. [1 ]
Stokkel, M. P. M. [1 ]
机构：
[1] Netherlands Canc Inst, Amsterdam, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2020年 / 47卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-276
引用
收藏
页码：S140 / S141
页数：2
相关论文
共 50 条
  • [41] Correction to: Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy
    Rudolf A. Werner
    Harun Ilhan
    Sebastian Lehner
    László Papp
    Norbert Zsótér
    Imke Schatka
    Dirk O. Muegge
    Mehrbod S. Javadi
    Takahiro Higuchi
    Andreas K. Buck
    Peter Bartenstein
    Frank Bengel
    Markus Essler
    Constantin Lapa
    Ralph A. Bundschuh
    Molecular Imaging and Biology, 2018, 20 : 1068 - 1068
  • [42] Overall outcome of peptide receptor radionuclide therapy (PRRT) in treatment metastatic progressive neuroendocrine tumors (NETs): Survival, toxicity and prognostic factors
    Alsadik, S. R.
    Gnanasegaran, G.
    Chen, L.
    Toumpanakis, C.
    Caplin, M.
    Navalkissoor, S.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 171 - 171
  • [43] Does Molecular Response Assessment after Peptide Receptor Radionuclide Therapy using Ga-68 Somatostatin Receptor PET/CT Offer an Additional Benefit?
    Kulkarni, H. R.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S200 - S200
  • [44] Surgical and Survival Outcomes of Early Peptide Receptor Radionuclide Therapy for Downstaging Locally Advanced or Oligometastatic Pancreatic Neuroendocrine Neoplasms
    Minczeles, N. S.
    van Eijck, C.
    van Gils, M. J.
    van Velthuysen, M. F.
    van Dijkum, Nieveen E. J. M.
    Feelders, R. A.
    de Herder, W. W.
    Brabander, T.
    Hofland, J.
    NEUROENDOCRINOLOGY, 2020, 110 : 267 - 267
  • [45] Dual-tracer PET/CT imaging in response assessment to peptide receptor radionuclide therapy - a case report
    Prospero, I.
    Ferreira, G.
    Ferro, J. C.
    Barbosa, D.
    Silva, D. G.
    Fontao de Castro, S.
    Teixeira, J. P.
    Duarte, H.
    Lucena Sampaio, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S218 - S218
  • [46] Characterizing Early Disease Progression in GEP-NET Patients After Peptide Receptor Radionuclide Therapy (PRRT)
    Kim, Suhyun
    Kim, Tae Young
    Kim, SunGyu
    Kim, Kwanghoon
    Sung, HyunPil
    Suh, Minseok
    Kang, Yeon-Koo
    Choi, Hongyoon
    Paeng, Jin Chul
    Cheon, Gi Jeong
    Kang, Keon Wook
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [47] Exploiting the DNA damage response to improve peptide receptor radionuclide therapy outcome
    Nonnekens, J.
    Van Kranenburg, M.
    De Jong, M.
    Van Gent, D.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S157 - S157
  • [48] Exploiting the DNA damage response to improve peptide receptor radionuclide therapy outcome
    Nonnekens, Julie
    van Kranenburg, Melissa
    Van Gent, Dik C.
    de Jong, Marion
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [49] Metastatic Insulinoma With Refractory Hypoglycemia With Complete Response to Peptide Receptor Radionuclide Therapy
    Duarte, Diana Borges
    Elvas, Ana Rita
    Couto, Joana
    Domingues, Isabel
    Oliveira, Sofia
    Martins, Raquel G.
    PANCREAS, 2022, 51 (09) : E110 - E112
  • [50] Angiogenic biomarkers of response to treatment with peptide receptor radionuclide therapy in neuroendocrine tumours
    Strzelczyk, Janusz
    Wojcik-Giertuga, Monika
    Makulik, Karolina
    Rosiek, Violetta
    Kaminski, Grzegorz
    Kajdaniuk, Dariusz
    Kos-Kudla, Beata
    ENDOKRYNOLOGIA POLSKA, 2024, 75 (04) : 412 - 418
12345